US Patent Issued to TCRCURE BIOPHARMA, GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY on Sept. 2 for "Anti-PD-1 antibodies and uses thereof" (California, Texas, Maryland Inventors)

ALEXANDRIA, Va., Sept. 3 -- United States Patent no. 12,404,331, issued on Sept. 2, was assigned to TCRCURE BIOPHARMA CORP. and GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY Co. LTD. (Guangzhou, China).

"Anti-PD-1 antibodies and uses thereof" was invented by Wei-Wu He (Sugarland, Texas), Paul Bryson (Alhambra, Calif.), Si Li (Alhambra, Calif.) and Donghui Ma (North Potomac, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to isolated monoclonal antibodies or antigen-binding fragments thereof that specifically bind to PD-1 and block the interaction between PD-1 and PD-L1/PD-L2. The disclosure also relates to antibodies that are chimeric, humanized, bispecific, derivatized, single chain anti...